• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拷贝数结构定义了治疗介导的致命前列腺癌克隆选择。

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.

机构信息

University College London Cancer Institute, London, UK.

University College London Hospitals, London, UK.

出版信息

Nat Commun. 2023 Aug 10;14(1):4823. doi: 10.1038/s41467-023-40315-9.

DOI:10.1038/s41467-023-40315-9
PMID:37563129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10415299/
Abstract

Despite initial responses to hormone treatment, metastatic prostate cancer invariably evolves to a lethal state. To characterize the intra-patient evolutionary relationships of metastases that evade treatment, we perform genome-wide copy number profiling and bespoke approaches targeting the androgen receptor (AR) on 167 metastatic regions from 11 organs harvested post-mortem from 10 men who died from prostate cancer. We identify diverse and patient-unique alterations clustering around the AR in metastases from every patient with evidence of independent acquisition of related genomic changes within an individual and, in some patients, the co-existence of AR-neutral clones. Using the genomic boundaries of pan-autosome copy number changes, we confirm a common clone of origin across metastases and diagnostic biopsies, and identified in individual patients, clusters of metastases occupied by dominant clones with diverged autosomal copy number alterations. These autosome-defined clusters are characterized by cluster-specific AR gene architectures, and in two index cases are topologically more congruent than by chance (p-values 3.07 × 10 and 6.4 × 10). Integration with anatomical sites suggests patterns of spread and points of genomic divergence. Here, we show that copy number boundaries identify treatment-selected clones with putatively distinct lethal trajectories.

摘要

尽管最初对激素治疗有反应,但转移性前列腺癌总是会发展为致命状态。为了描述逃避治疗的转移性肿瘤的患者内进化关系,我们对 10 名死于前列腺癌的男性死后从 11 个器官中采集的 167 个转移性区域进行了全基因组拷贝数分析,并针对雄激素受体 (AR) 进行了定制方法。我们在每个患者的转移灶中都发现了围绕 AR 的不同且患者特有的改变,这些改变表明在个体中独立获得了相关的基因组变化,并且在一些患者中,AR 中性克隆同时存在。使用泛着丝粒拷贝数变化的基因组边界,我们确认了转移灶和诊断性活检之间存在共同的克隆起源,并在个别患者中,确定了由具有不同常染色体拷贝数改变的优势克隆占据的转移灶簇。这些由染色体定义的簇的特征是簇特异性的 AR 基因结构,在两个指数病例中,拓扑结构比随机更一致(p 值分别为 3.07×10 和 6.4×10)。与解剖部位的整合表明了传播模式和基因组分歧点。在这里,我们表明,拷贝数边界可以识别出具有潜在不同致死轨迹的治疗选择克隆。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/4811901bd479/41467_2023_40315_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/51c6214182fb/41467_2023_40315_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/7094374a90f5/41467_2023_40315_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/075d9c31c41a/41467_2023_40315_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/31728afd3982/41467_2023_40315_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/4811901bd479/41467_2023_40315_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/51c6214182fb/41467_2023_40315_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/7094374a90f5/41467_2023_40315_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/075d9c31c41a/41467_2023_40315_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/31728afd3982/41467_2023_40315_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662b/10415299/4811901bd479/41467_2023_40315_Fig5_HTML.jpg

相似文献

1
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.拷贝数结构定义了治疗介导的致命前列腺癌克隆选择。
Nat Commun. 2023 Aug 10;14(1):4823. doi: 10.1038/s41467-023-40315-9.
2
Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.通过对单个循环肿瘤细胞的高内涵分析推断,前列腺癌在治疗压力下的快速表型和基因组变化。
PLoS One. 2014 Aug 1;9(8):e101777. doi: 10.1371/journal.pone.0101777. eCollection 2014.
3
Tumor clone dynamics in lethal prostate cancer.致命性前列腺癌中的肿瘤克隆动态变化
Sci Transl Med. 2014 Sep 17;6(254):254ra125. doi: 10.1126/scitranslmed.3009448.
4
Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.未经治疗的前列腺癌中雄激素受体基因拷贝数与蛋白表达
Urol Int. 2017;99(2):222-228. doi: 10.1159/000455158. Epub 2017 Jan 5.
5
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.一种新型 DNA 甲基化特征与骨转移前列腺癌中的雄激素受体活性和患者预后相关。
Clin Epigenetics. 2021 Jun 30;13(1):133. doi: 10.1186/s13148-021-01119-0.
6
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.游离 DNA 中的基因组改变与恩杂鲁胺耐药在去势抵抗性前列腺癌中的作用
JAMA Oncol. 2016 Dec 1;2(12):1598-1606. doi: 10.1001/jamaoncol.2016.0494.
7
The evolutionary history of lethal metastatic prostate cancer.致死性转移性前列腺癌的进化史。
Nature. 2015 Apr 16;520(7547):353-357. doi: 10.1038/nature14347. Epub 2015 Apr 1.
8
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer.基于免疫组织化学的转移性去势抵抗性前列腺癌雄激素受体状态和 AR 缺失表型评估。
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):507-516. doi: 10.1038/s41391-020-0214-6. Epub 2020 Feb 24.
9
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer.去势抵抗性前列腺癌基因组中的常见结构和表观遗传改变。
Cancer Res. 2012 Feb 1;72(3):616-25. doi: 10.1158/0008-5472.CAN-11-2079. Epub 2011 Dec 7.
10
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.转移性前列腺癌的基因组特征和结构变异。
Cell. 2018 Jul 26;174(3):758-769.e9. doi: 10.1016/j.cell.2018.06.039. Epub 2018 Jul 19.

引用本文的文献

1
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer.转座元件的遗传和表观遗传重编程驱动ecDNA介导的转移性前列腺癌。
bioRxiv. 2025 Aug 12:2025.08.08.668693. doi: 10.1101/2025.08.08.668693.
2
Uncovering phenotypic heterogeneity through research autopsy in lethal prostate cancer.通过对致命性前列腺癌进行研究性尸检揭示表型异质性。
J Clin Invest. 2025 Aug 1;135(15). doi: 10.1172/JCI195102.
3
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer.致命性前列腺癌瘤内和瘤间表型异质性模式

本文引用的文献

1
Development of 2-(5,6,7-Trifluoro-1-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer.开发 2-(5,6,7-三氟-1-吲哚-3-基)-喹啉-5-甲酰胺作为一种有效的、选择性的、口服可用的人雄激素受体抑制剂,靶向其结合功能-3,用于治疗去势抵抗性前列腺癌。
J Med Chem. 2021 Oct 28;64(20):14968-14982. doi: 10.1021/acs.jmedchem.1c00681. Epub 2021 Oct 18.
2
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer.液体活检中的 AR 基因重排分析揭示了致命性前列腺癌的异质性。
Endocr Relat Cancer. 2021 Aug 11;28(9):645-655. doi: 10.1530/ERC-21-0157.
3
J Clin Invest. 2025 Jun 10;135(15). doi: 10.1172/JCI186599. eCollection 2025 Aug 1.
4
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers.转移性前列腺癌的精准靶向治疗:治疗前沿的分子见解
Biomolecules. 2025 Apr 27;15(5):625. doi: 10.3390/biom15050625.
5
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance.治疗诱导的干性和谱系可塑性在驱动前列腺癌治疗耐药性中的作用
Cancer Heterog Plast. 2024;1(1). doi: 10.47248/chp2401010005. Epub 2024 Aug 25.
6
Chromosomal instability as a driver of cancer progression.染色体不稳定性作为癌症进展的驱动因素。
Nat Rev Genet. 2025 Jan;26(1):31-46. doi: 10.1038/s41576-024-00761-7. Epub 2024 Jul 29.
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.
ctDNA 中连续雄激素受体通路抑制下前列腺癌去势抵抗的演变。
Clin Cancer Res. 2021 Aug 15;27(16):4610-4623. doi: 10.1158/1078-0432.CCR-21-1625. Epub 2021 Jun 3.
4
Accurate and efficient detection of gene fusions from RNA sequencing data.从 RNA 测序数据中准确高效地检测基因融合。
Genome Res. 2021 Mar;31(3):448-460. doi: 10.1101/gr.257246.119. Epub 2021 Jan 13.
5
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.前列腺癌从多谱系原发性到单谱系转移的演进及其对液体活检的影响。
Nat Commun. 2020 Oct 8;11(1):5070. doi: 10.1038/s41467-020-18843-5.
6
Pervasive chromosomal instability and karyotype order in tumour evolution.肿瘤进化中的普遍染色体不稳定性和核型顺序。
Nature. 2020 Nov;587(7832):126-132. doi: 10.1038/s41586-020-2698-6. Epub 2020 Sep 2.
7
Copy number evolution with weighted aberrations in cancer.癌症中具有加权异常的拷贝数进化。
Bioinformatics. 2020 Jul 1;36(Suppl_1):i344-i352. doi: 10.1093/bioinformatics/btaa470.
8
Diverse Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer.多种基因重排介导转移性前列腺癌对雄激素受体抑制剂的耐药性。
Clin Cancer Res. 2020 Apr 15;26(8):1965-1976. doi: 10.1158/1078-0432.CCR-19-3023. Epub 2020 Jan 13.
9
Genomic correlates of clinical outcome in advanced prostate cancer.晚期前列腺癌的临床结局的基因组相关性。
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6.
10
ACE: absolute copy number estimation from low-coverage whole-genome sequencing data.ACE:基于低覆盖度全基因组测序数据的绝对拷贝数估计。
Bioinformatics. 2019 Aug 15;35(16):2847-2849. doi: 10.1093/bioinformatics/bty1055.